We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 0.26% | 38.35 | 38.25 | 38.35 | 38.35 | 38.35 | 38.35 | 114,425 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 3.1M | -6.51M | -0.0217 | -17.67 | 115.32M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/2/2024 11:59 | Like everyone else I have left an anonymous review and do not plan to divulge that level of personal data on the quality of the experience - you will have to simply infer from my postings - sorry. But I am not really a client as I am healthy in that respect but was wanting to understand the physiological effects etc. dyor and no advice etc | takeiteasy | |
21/2/2024 11:50 | Eroxon Amazon sales 4000+ in the past monthErexOn Amazon sales 200+ in the past month:- ) | broomrigg | |
21/2/2024 11:24 | Erexon: 328 out of 420 (78%) reviewers recommend this product Eroxon: 336 out of 449 (75%) reviewers don't recommend this product | glavey | |
21/2/2024 10:48 | It's going to be available on NHS prescription from the 1st of March, yet you feel the need to do your own non-randomised clinical trial ? | wheeze | |
21/2/2024 10:44 | Have any investors on this board tried the product? What was your experience with it? Do you find that cutting out tea and using coffee instead more effective? Is horny goat weed more effective than Eroxon in your experience? | martywidget | |
21/2/2024 08:18 | If I was an MM here I would do what they are doing and move down the bid for stop losses - continual surprise how many this picks up each time given the news...hopefully they will happy to stop at 39p and not 35p this time :) dyor etc | takeiteasy | |
21/2/2024 06:25 | Well done takeiteasy, he hates being silenced. MDI (aka LBO) is a bitter ex shareholder who lost all his money by selling his FUM shares sub 10p in 2018. He bought high and sold at the all-time low. It's as simple as that. :- ) | broomrigg | |
20/2/2024 21:27 | Petroc, I do not mind someone saying they don;t like the company , the management, the products, the history and whether they are short or not I do not really care either. What is being done here is to repost mindlessly partial extracts from a scenario that paints an entirely misleading picture of the status quo. Simply refusing to acknowledge the 60% test outcome when this is fact and restating that this is still a placebo product under the new guise (it was under the old but not new) that needs a double blind trial. It may mean that you can avoid rules of deliberately misleading as you fall back on "I'm only cut and pasting what's in the public domain' and "I'm not expressing an opinion am I" BS, but this person has done this to an extreme that defies sanity. He clearly has taken legal advice and so no one can stop him...anyway I will never see his comments again so am delighted to not read the same thing all day every day... | takeiteasy | |
20/2/2024 18:32 | Absolutely spot on there petroc, he is not a shorter or part of some kind of cartel. He's simply a bitter broke nutjob. Deranged. Demented. For a more balanced, honest, uninterrupted discussion LSE is very good. | broomrigg | |
20/2/2024 16:32 | I have managed the position size here - so am very chilled really. It is a much bigger industry thing - we are hopefully likely to massively disrupt a cosy cartel of interests in the ED industry who are making large profits year after year and will of course compete hard not to lose that business to a new rival. I did filter this chap a while back and relented (in error) and will not do so again :) I get your point over the shorters - it seems to me just brainless to keep picking on a share like this one after our recent news. But their money and their choice. dyor and no advice implied... | takeiteasy | |
20/2/2024 16:23 | Takeiteasy, Take it easy mate - don't let the shorters get you down. You will find blatant deramping of many stocks by punters following the likes of Tommy Williefroth - there is often a wall of money thrown at driving a share down. Plenty of bulletin board trolls posting drivel just to put investors off. My own philosophy is:Do your own research Make your own choices Don't let the trolls get you down Take it easy | wheeze | |
20/2/2024 15:25 | I think I have been on ADVFN for many many years and have never ever come across a board like this one - perhaps I typically keep away from AIM stocks and all the smaller company boards are like this - who knows...it is a great shame that the moderators are so limp in their approach and need to build a stiffer backbone..infuse themselves in Eroxon more like... | takeiteasy | |
20/2/2024 15:19 | ‘There was a double blind placebo trial’ Yes it was a Phase 3 drug trial set up and designed to study a completely different GTN gel. It was not a trial set up and designed to study the placebo Eroxon gel. The results of that failed phase 3 GTN gel drug study do not clinically prove that Eroxon which was the placebo gel in that study is not just a placebo gel. The company that makes MED3000 (Eroxon) also made a different compound called MED2005, a nitroglycerine-conta This means that about one man out of nine who used the active drug found it more helpful than a placebo. It also means that most people who were satisfied with the results were having a placebo response | mdi | |
20/2/2024 15:18 | That's probably him loading up long last trade with 50k shares on the shake out... | takeiteasy | |
20/2/2024 15:12 | Don't worry he makes no difference to the share price or the worldwide rollout of Eroxon. | broomrigg | |
20/2/2024 15:11 | Also a CE Mark for a low class medical device does not mean efficacy is proven either. Eroxon Is Not a Medication? No. Because it lacks an active ingredient, the EU granted MED3000 a CE mark which classifies it as a medical device not a medication. Thats important because in European markets, medical devices dont have to show any sort of improvement in symptoms; they just have to meet specific safety standards. In other words, the CE mark proves only that Eroxon is safe, not that it works. Does it work? MED3000 was recently granted a CE mark as an approved medical device in the EU. Does this mean it works? No. Unlike drugs, medical devices don't need to be proven efficacious to be sold; they only need to show conformity with safety regulations, which the CE mark indicates. So how effective is MED3000 really? The first thing to note is that MED3000 has never been shown to be more effective than any control treatment - because it was the control treatment. When Futura describe the efficacy of MED3000, they are talking about improvement seen over the course of the treatment period (which was 1 month in the first trial, 3 months in the second), known as 'change vs. baseline'. Large improvements vs. baseline are common in the placebo groups in clinical trials of a wide range of conditions. This improvement is sometimes attributed to the 'placebo effect', | mdi | |
20/2/2024 15:10 | MDI - filtered. There was a double blind placebo trial - it met the end point. Yes, you may drive the price back down to 35p with all this nonsense - but as I said before you have lost the argument. | takeiteasy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions